ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 30 filers reported holding ACHILLES THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $588,000 | -17.8% | 233,180 | -4.2% | 0.01% | -25.0% |
| Q1 2022 | $715,000 | -56.0% | 243,296 | -25.0% | 0.01% | -47.8% |
| Q4 2021 | $1,625,000 | +114.4% | 324,387 | +319.2% | 0.02% | +64.3% |
| Q2 2021 | $758,000 | -80.8% | 77,386 | -67.6% | 0.01% | -84.1% |
| Q1 2021 | $3,953,000 | – | 238,822 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 11,086,909 | $10,087,979 | 15.03% |
| Artal Group S.A. | 2,255,375 | $2,052 | 0.09% |
| Redmile Group, LLC | 1,608,089 | $1,463,200 | 0.07% |
| Forefront Analytics, LLC | 78,169 | $71,126 | 0.04% |
| Baker Brothers Advisors | 2,557,149 | $2,326,750 | 0.01% |
| Point72 Asset Management, L.P. | 1,413,809 | $1,286,425 | 0.00% |
| XTX Topco Ltd | 21,084 | $19,184 | 0.00% |
| Coppell Advisory Solutions LLC | 1,000 | $5,560 | 0.00% |
| Renaissance Technologies | 437,528 | $398 | 0.00% |
| JPMORGAN CHASE & CO | 989 | $900 | 0.00% |